推荐产品
等级
pharmaceutical primary standard
API类
naloxone
制造商/商品名称
USP
应用
pharmaceutical (small molecule)
格式
neat
储存温度
2-8°C
InChI
1S/C19H21NO4/c1-2-8-20-9-7-18-15-11-3-4-12(21)16(15)24-17(18)13(22)5-6-19(18,23)14(20)10-11/h2-4,14,17,21,23H,1,5-10H2/t14-,17+,18+,19-/m1/s1
InChI key
UZHSEJADLWPNLE-GRGSLBFTSA-N
一般描述
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
应用
Naloxone USP Reference standard for use in specified quality tests and assays.
Also used to prepare standard, system suitability, and Sensitivity solution for the assay, identification, impurity analysis, and performance test by liquid chromatography coupled with UV detector in accordance with the given below monographs of united states pharmacopeia (USP) :
Also used to prepare standard, system suitability, and Sensitivity solution for the assay, identification, impurity analysis, and performance test by liquid chromatography coupled with UV detector in accordance with the given below monographs of united states pharmacopeia (USP) :
- Naloxone Hydrochloride
- Buprenorphine and Naloxone Sublingual Tablets
- Pentazocine and Naloxone Tablets
分析说明
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
其他说明
Sales restrictions may apply.
相关产品
产品编号
说明
价格
警示用语:
Warning
危险声明
危险分类
Acute Tox. 4 Oral
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
监管及禁止进口产品
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 39(8), 1852-1860 (2014-02-13)
Although the underlying mechanism remains unknown, several studies have suggested benefits of n-3 long-chain polyunsaturated fatty acid (PUFA) for patients with anxiety disorders. Elevated fear is thought to contribute to the pathogenesis of particular anxiety disorders. The aim of the
Pentazocine and Naloxone Tablets
United States Pharmacopeia, 45(1), 3463-3463 (2023)
Naloxone Hydrochloride
United States Pharmacopeia, 46(2) (2022)
Buprenorphine and Naloxone Sublingual Tablets
United States Pharmacopeia, 42(3), 616-616 (2020)
British journal of pharmacology, 171(15), 3693-3701 (2014-04-25)
CR4056 is a novel imidazoline-2 (I2 ) ligand exhibiting potent analgesic activity in animal models of pain. In this study, we investigated the effects of CR4056 in a well-established model of postoperative pain where rats develop hyperalgesia in the injured
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门